Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 1,086

The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.

Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline

Open access
Crouser, Elliott D., Maier, Lisa A., Wilson, Kevin C., Bonham, Catherine A., Morgenthau, Adam S., Patterson, Karen C., Abston, Eric, Bernstein, Richard C., Blankstein, Ron, Chen, Edward S., Culver, Daniel A., Drake, Wonder, Drent, Marjolein, Gerke, Alicia K., Ghobrial, Michael, Govender, Praveen, Hamzeh, Nabeel, James, W. Ennis, Judson, Marc A., Kellermeyer, Liz, Knight, Shandra, Koth, Laura L., Poletti, Venerino, Raman, Subha V., Tukey, Melissa H., Westney, Gloria E., Baughman, Robert P. · 2020 · American Journal of Respiratory and Critical Care Medicine

Abstract

Abstract Background The diagnosis of sarcoidosis is not standardized but is based on three major criteria: a compatible clinical presentation, finding nonnecrotizing granulomatous inflammation in one or more tissue samples, and the exclusion of alternative causes of granulomatous disease. There are no universally accepted measures to determine if each diagnostic criterion has been satisfied; therefore, the diagnosis of sarcoidosis is never fully secure. Methods Systematic reviews and, when appropriate, meta-analyses were performed to summarize the best available evidence. The evidence was appraised using the Grading of Recommendations, Assessment, Development, and Evaluation approach and then discussed by a multidisciplinary panel. Recommendations for or against various diagnostic tests were formulated and graded after the expert panel weighed desirable and undesirable consequences, certainty of estimates, feasibility, and acceptability. Results The clinical presentation, histopathology, and exclusion of alternative diagnoses were summarized. On the basis of the available evidence, the expert committee made 1 strong recommendation for baseline serum calcium testing, 13 conditional recommendations, and 1 best practice statement. All evidence was very low quality. Conclusions The panel used systematic reviews of the evidence to inform clinical recommendations in favor of or against various diagnostic tests in patients with suspected or known sarcoidosis. The evidence and recommendations should be revisited as new evidence becomes available.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.202002-0251st

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 105

  1. Grunewald, 2007, Sex-specific manifestations of Löfgren’s syndrome, Am J Respir Crit Care Med, 175, 40, 10.1164/rccm.200608-1197OC · doi:10.1164/rccm.200608-1197oc
  2. Winterbauer, 1973, Clinical interpretation of bilateral hilar adenopathy, Ann Intern Med, 78, 65, 10.7326/0003-4819-78-1-65 · doi:10.7326/0003-4819-78-1-65
  3. Amicosante, 2011, IGRAs for tuberculosis in sarcoidosis patients: is the immune response to mycobacteria helpful in the differential diagnosis or still a confounding factor?, Sarcoidosis Vasc Diffuse Lung Dis, 28, 85
  4. Nin, 2016, Thoracic lymphadenopathy in benign diseases: a state of the art review, Respir Med, 112, 10, 10.1016/j.rmed.2016.01.021 · doi:10.1016/j.rmed.2016.01.021
  5. Balmes, 2014, An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease, Am J Respir Crit Care Med, 190, e34, 10.1164/rccm.201409-1722ST · doi:10.1164/rccm.201409-1722st
  6. Payá-Llorente, 2018, Mediastinal sarcoid-like reaction in cancer patients, Pulmonology, 24, 61, 10.1016/j.pulmoe.2017.12.003 · doi:10.1016/j.pulmoe.2017.12.003
  7. Carmona, 2016, Pulmonary sarcoidosis: diagnosis and treatment, Mayo Clin Proc, 91, 946, 10.1016/j.mayocp.2016.03.004 · doi:10.1016/j.mayocp.2016.03.004
  8. Boujaoude, 2012, Endobronchial ultrasound with transbronchial needle aspiration in the diagnosis of bilateral hilar and mediastinal lymphadenopathy, J Bronchology Interv Pulmonol, 19, 19, 10.1097/LBR.0b013e3182442b89 · doi:10.1097/lbr.0b013e3182442b89
  9. Garwood, 2007, Endobronchial ultrasound for the diagnosis of pulmonary sarcoidosis, Chest, 132, 1298, 10.1378/chest.07-0998 · doi:10.1378/chest.07-0998
  10. Hong, 2013, Usefulness of endobronchial ultrasound guided transbronchial needle aspiration for diagnosis of sarcoidosis, Yonsei Med J, 5, 1416, 10.3349/ymj.2013.54.6.1416 · doi:10.3349/ymj.2013.54.6.1416
  11. Iwashita, 2008, The yield of endoscopic ultrasound-guided fine needle aspiration for histological diagnosis in patients suspected of stage I sarcoidosis, Endoscopy, 40, 400, 10.1055/s-2007-995593 · doi:10.1055/s-2007-995593
  12. Koerner, 1975, Transbronchinal lung biopsy for the diagnosis of sarcoidosis, N Engl J Med, 293, 268, 10.1056/NEJM197508072930603 · doi:10.1056/nejm197508072930603
  13. Koonitz, 1976, Transbronchial lung biopsy via the fiberoptic bronchoscope in sarcoidosis, Ann Intern Med, 85, 64, 10.7326/0003-4819-85-1-64 · doi:10.7326/0003-4819-85-1-64
  14. Leonard, 1997, Bronchoscopic diagnosis of sarcoidosis, Eur Respir J, 10, 2722, 10.1183/09031936.97.10122722 · doi:10.1183/09031936.97.10122722
  15. Oki, 2007, Real-time endobronchial ultrasound-guided transbronchial needle aspiration is useful for diagnosing sarcoidosis, Respirology, 12, 863, 10.1111/j.1440-1843.2007.01145.x · doi:10.1111/j.1440-1843.2007.01145.x
  16. Pakhale, 2006, Has mediastinoscopy still a role in suspected stage I sarcoidosis?, Sarcoidosis Vasc Diffuse Lung Dis, 23, 66
  17. Pauli, 1984, Transbronchial needle aspiration in the diagnosis of sarcoidosis, Chest, 85, 482, 10.1378/chest.85.4.482 · doi:10.1378/chest.85.4.482
  18. Ribeiro, 2014, Diagnosis of sarcoidosis in the endobronchial ultrasound-guided transbronchial needle aspiration era, Rev Port Pneumol, 20, 237, 10.1016/j.rppneu.2014.02.005 · doi:10.1016/j.rppneu.2014.02.005
  19. Trisolini, 2004, Transbronchial needle aspiration improves the diagnostic yield of bronchoscopy in sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 21, 147
  20. Oki, 2012, Prospective study of endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes versus transbronchial lung biopsy of lung tissue for diagnosis of sarcoidosis, J Thorac Cardiovasc Surg, 143, 1324, 10.1016/j.jtcvs.2012.01.040 · doi:10.1016/j.jtcvs.2012.01.040
  21. Oki, 2013, Transesophageal bronchoscopic ultrasound-guided fine needle aspiration for diagnosis of sarcoidosis, Respiration, 85, 137, 10.1159/000345207 · doi:10.1159/000345207
  22. Oki, 2018, How many passes are needed for endobronchial ultrasound-guided transbronchial needle aspiration for sarcoidosis? A prospective multicenter study, Respiration, 95, 251, 10.1159/000485661 · doi:10.1159/000485661
  23. Yanardağ, 2006, Clinical value of mediastinoscopy in the diagnosis of sarcoidosis: an analysis of 68 cases, Thorac Cardiovasc Surg, 54, 198, 10.1055/s-2005-872996 · doi:10.1055/s-2005-872996
  24. Friedel, 1964, The significance of bronchoscopy and mediastinoscopy for the diagnosis of sarcoidosis [in German], Z Tuberk Erkrank Thoraxorg, 121, 152
  25. Balwan, 2018, Endobronchial ultrasound-guided transbronchial needle aspiration using 19-G needle for sarcoidosis, J Bronchology Interv Pulmonol, 25, 260, 10.1097/LBR.0000000000000502 · doi:10.1097/lbr.0000000000000502
  26. Szlubowski, 2008, Ultrasound guided transbronchial needle aspiration as a diagnostic tool for lung cancer and sarcoidosis [in Polish], Pneumonol Alergol Pol, 76, 229
  27. Li, 2014, A randomized controlled study of conventional TBNA versus EBUS-TBNA for diagnosis of suspected stage I and II sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 31, 211
  28. Low, 2014, Use of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in the diagnosis of granulomatous mediastinal lymphadenopathy, Ann Acad Med Singapore, 43, 250, 10.47102/annals-acadmedsg.V43N5p250 · doi:10.47102/annals-acadmedsg.v43n5p250
  29. Navasakulpong, 2016, Yield of EBUS-TBNA for the diagnosis of sarcoidosis: impact of operator and cytopathologist experience, BMJ Open Respir Res, 3, e000144, 10.1136/bmjresp-2016-000144 · doi:10.1136/bmjresp-2016-000144
  30. Raddaoui, 2014, Utility of endoscopic ultrasound-guided transbronchial fine-needle cytology in the diagnosis of sarcoidosis: a Saudi experience, Cytojournal, 11, 31, 10.4103/1742-6413.146118 · doi:10.4103/1742-6413.146118
  31. Wong, 2007, Endobronchial ultrasound: new insight for the diagnosis of sarcoidosis, Eur Respir J, 29, 1182, 10.1183/09031936.00028706 · doi:10.1183/09031936.00028706
  32. Tucker, 1970, Mediastinoscopy with special reference to the diagnosis of sarcoid, Ann Otol Rhinol Laryngol, 79, 937, 10.1177/000348947007900510 · doi:10.1177/000348947007900510
  33. Carlens, 1959, Mediastinoscopy: a method for inspection and tissue biopsy in the superior mediastinum, Dis Chest, 36, 343, 10.1378/chest.36.4.343 · doi:10.1378/chest.36.4.343
  34. Nielsen, 1966, Mediastinoscopy: an analysis of 223 cases, Dan Med Bull, 13, 193
  35. Maassen, 1967, Results and significance of mediastinoscopy and other procedures of thoracic biopsy [in German], Tuberk Grenzgeb Einzeldarst, 19, 1
  36. Jepsen, 1966, Mediastinoscopy
  37. Löfgren, 1964, Principles and procedures for obtaining biopsies in sarcoidosis, Acta Med Scand Suppl, 425, 225, 10.1111/j.0954-6820.1964.tb05756.x · doi:10.1111/j.0954-6820.1964.tb05756.x
  38. Palva, 1964, Mediastinal sarcoidosis, Acta Otolaryngol Suppl, 188
  39. Pätiälä, 1964, Observations on the significance of mediastinoscopy in the diagnosis of sarcoidosis, Acta Med Scand Suppl, 425, 239, 10.1111/j.0954-6820.1964.tb05761.x · doi:10.1111/j.0954-6820.1964.tb05761.x
  40. Mikhail, 1971, Mediastinoscopy: a diagnostic procedure in hilar and paratracheal lymphadenopathy, Postgrad Med J, 47, 698, 10.1136/pgmj.47.553.698 · doi:10.1136/pgmj.47.553.698
  41. Bergh, 1964, Mediastinal exploration by the technique of Carlens, Dis Chest, 46, 399, 10.1378/chest.46.4.399 · doi:10.1378/chest.46.4.399
  42. Lemaire, 2006, Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate, Ann Thorac Surg, 82, 1185, 10.1016/j.athoracsur.2006.05.023 · doi:10.1016/j.athoracsur.2006.05.023
  43. Cybulsky, 1994, Mediastinoscopy as a routine outpatient procedure, Ann Thorac Surg, 58, 176, 10.1016/0003-4975(94)91095-2 · doi:10.1016/0003-4975(94)91095-2
  44. Steinfort, 2010, Cost-benefit of minimally invasive staging of non–small cell lung cancer: a decision tree sensitivity analysis, J Thorac Oncol, 5, 1564, 10.1097/JTO.0b013e3181e8b2e6 · doi:10.1097/jto.0b013e3181e8b2e6
  45. Li, 2015, Mediastinoscopy after negative endoscopic mediastinal nodal staging: can it be omitted?, Eur Respir J, 46, 1846, 10.1183/13993003.01166-2015 · doi:10.1183/13993003.01166-2015
  46. Shrager, 2010, Mediastinoscopy: still the gold standard, Ann Thorac Surg, 89, S2084, 10.1016/j.athoracsur.2010.02.098 · doi:10.1016/j.athoracsur.2010.02.098
  47. Hu, 2016, Endobronchial ultrasound-guided transbronchial needle aspiration versus standard bronchoscopic modalities for diagnosis of sarcoidosis: a meta-analysis, Chin Med J (Engl), 129, 1607, 10.4103/0366-6999.184458 · doi:10.4103/0366-6999.184458
  48. Gnass, 2015, Comparison of conventional and ultrasound-guided needle biopsy techniques in the diagnosis of sarcoidosis: a randomized trial, Pol Arch Med Wewn, 125, 321, 10.20452/pamw.2828 · doi:10.20452/pamw.2828
  49. Liran, 2019, A novel, stepwise approach combining conventional and endobronchial ultrasound needle aspiration for mediastinal lymph node sampling, Endosc Ultrasound, 8, 31, 10.4103/eus.eus_29_17 · doi:10.4103/eus.eus_29_17
  50. Acharya, 2018, Distinguishing features of ocular sarcoidosis in an international cohort of uveitis patients, Ophthalmology, 125, 119, 10.1016/j.ophtha.2017.07.006 · doi:10.1016/j.ophtha.2017.07.006
  51. Birnbaum, 2015, Sarcoidosis in the national veteran population: association of ocular inflammation and mortality, Ophthalmology, 122, 934, 10.1016/j.ophtha.2015.01.003 · doi:10.1016/j.ophtha.2015.01.003
  52. Dróbecka, 1999, Ocular manifestations in sarcoidosis [in Polish], Klin Oczna, 101, 201
  53. Atmaca, 2009, Ocular involvement in sarcoidosis, Ocul Immunol Inflamm, 17, 91, 10.1080/09273940802596526 · doi:10.1080/09273940802596526
  54. James, 1964, Ocular sarcoidosis, Br J Ophthalmol, 48, 461, 10.1136/bjo.48.9.461 · doi:10.1136/bjo.48.9.461
  55. Jackson, 1970, Ocular sarcoidosis, Postgrad Med J, 46, 501, 10.1136/pgmj.46.538.501 · doi:10.1136/pgmj.46.538.501
  56. Obenauf, 1978, Sarcoidosis and its ophthalmic manifestations, Am J Ophthalmol, 86, 648, 10.1016/0002-9394(78)90184-8 · doi:10.1016/0002-9394(78)90184-8
  57. Khanna, 2007, Pattern of ocular manifestations in patients with sarcoidosis in developing countries, Acta Ophthalmol Scand, 85, 609, 10.1111/j.1600-0420.2006.00791.x · doi:10.1111/j.1600-0420.2006.00791.x
  58. Sungur, 2013, Pattern of ocular findings in patients with biopsy-proven sarcoidosis in Turkey, Ocul Immunol Inflamm, 21, 455, 10.3109/09273948.2013.775311 · doi:10.3109/09273948.2013.775311
  59. Sheu, 2010, Ocular sarcoidosis in southern taiwan, Ocul Immunol Inflamm, 18, 152, 10.3109/09273941003637502 · doi:10.3109/09273941003637502
  60. Pefkianaki, 2011, Ocular disease awareness and pattern of ocular manifestation in patients with biopsy-proven lung sarcoidosis, J Ophthalmic Inflamm Infect, 1, 141, 10.1007/s12348-011-0029-7 · doi:10.1007/s12348-011-0029-7
  61. Mochizuki, 2019, Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis, Br J Ophthalmol, 103, 1418, 10.1136/bjophthalmol-2018-313356 · doi:10.1136/bjophthalmol-2018-313356
  62. Ohara, 1992, Intraocular manifestations of systemic sarcoidosis, Jpn J Ophthalmol, 36, 452
  63. Yang, 2017, Ocular sarcoidosis: new diagnostic modalities and treatment, Curr Opin Pulm Med, 23, 458, 10.1097/MCP.0000000000000409 · doi:10.1097/mcp.0000000000000409
  64. Richmond, 1981, Renal disease and sarcoidosis, Med J Aust, 2, 36, 10.5694/j.1326-5377.1981.tb132055.x · doi:10.5694/j.1326-5377.1981.tb132055.x
  65. MacSearraigh, 1978, Sarcoidosis with renal involvement, Postgrad Med J, 54, 528, 10.1136/pgmj.54.634.528 · doi:10.1136/pgmj.54.634.528
  66. Lebacq, 1970, Renal involvement in sarcoidosis, Postgrad Med J, 46, 526, 10.1136/pgmj.46.538.526 · doi:10.1136/pgmj.46.538.526
  67. Löfgren, 1957, Renal complications in sarcoidosis; functional and biopsy studies, Acta Med Scand, 159, 295, 10.1111/j.0954-6820.1957.tb00137.x · doi:10.1111/j.0954-6820.1957.tb00137.x
  68. Kahi, 2006, Hepatobiliary disease in sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 23, 117
  69. Kennedy, 2006, Natural history of hepatic sarcoidosis and its response to treatment, Eur J Gastroenterol Hepatol, 18, 721, 10.1097/01.meg.0000223911.85739.38 · doi:10.1097/01.meg.0000223911.85739.38
  70. Cowdell, 1954, Sarcoidosis: with special reference to diagnosis and prognosis, Q J Med, 23, 29
  71. Baughman, 2003, Role of liver function tests in detecting methotrexate-induced liver damage in sarcoidosis, Arch Intern Med, 163, 615, 10.1001/archinte.163.5.615 · doi:10.1001/archinte.163.5.615
  72. Van Brusselen, 2012, Budd-Chiari syndrome as presenting symptom of hepatic sarcoidosis in a child, with recurrence after liver transplantation, Pediatr Transplant, 16, E58, 10.1111/j.1399-3046.2011.01535.x · doi:10.1111/j.1399-3046.2011.01535.x
  73. Sexton, 2016, Serum fibroblastic growth factor 23 in acute sarcoidosis and normal kidney function, Sarcoidosis Vasc Diffuse Lung Dis, 33, 139
  74. James, 1956, Diagnosis and treatment of sarcoidosis, BMJ, 2, 900, 10.1136/bmj.2.4998.900 · doi:10.1136/bmj.2.4998.900
  75. McCort, 1947, Sarcoidosis a clinical and roentgenologic study of twenty-eight proved cases, Arch Intern Med (Chic), 80, 293, 10.1001/archinte.1947.00220150003001 · doi:10.1001/archinte.1947.00220150003001
  76. Ferguson, 1958, Sarcoidosis; study of twenty-nine cases, with a review of splenic, hepatic, mucous-membrane; retinal, and joint manifestations, AMA Arch Intern Med, 101, 1065, 10.1001/archinte.1958.00260180055007 · doi:10.1001/archinte.1958.00260180055007
  77. Cummings, 1959, Epidemiologic and clinical observations in sarcoidosis, Ann Intern Med, 50, 879, 10.7326/0003-4819-50-4-879 · doi:10.7326/0003-4819-50-4-879
  78. Kavathia, 2010, Elevated 1, 25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis, Respir Med, 104, 564, 10.1016/j.rmed.2009.12.004 · doi:10.1016/j.rmed.2009.12.004
  79. Kamphuis, 2014, Calcium and vitamin D in sarcoidosis: is supplementation safe?, J Bone Miner Res, 29, 2498, 10.1002/jbmr.2262 · doi:10.1002/jbmr.2262
  80. Thomas, 1987, Current concepts of the pathogenesis of sarcoidosis, Am Rev Respir Dis, 135, 747
  81. Browne, 1978, Bone marrow sarcoidosis, JAMA, 240, 2654, 10.1001/jama.1978.03290240054026 · doi:10.1001/jama.1978.03290240054026
  82. Yanardağ, 2002, Bone marrow involvement in sarcoidosis: an analysis of 50 bone marrow samples, Haematologia (Budap), 32, 419
  83. Gupta, 2002, Haematological abnormalities in patients of sarcoidosis, Indian J Chest Dis Allied Sci, 44, 233
  84. Sharma, 2001, Clinical characteristics, pulmonary function abnormalities and outcome of prednisolone treatment in 106 patients with sarcoidosis, J Assoc Physicians India, 49, 697
  85. Israel, 1958, Sarcoidosis; clinical observation on one hundred sixty cases, AMA Arch Intern Med, 102, 766, 10.1001/archinte.1958.00260220082008 · doi:10.1001/archinte.1958.00260220082008
  86. Langer, 1995, Electrocardiographic changes in patients with intrathoracic sarcoidosis: influence on prognosis, Sarcoidosis, 12, 42
  87. Stanton, 2017, The utility of cardiac magnetic resonance imaging in the diagnosis of cardiac sarcoidosis, Heart Lung Circ, 26, 1191, 10.1016/j.hlc.2017.02.021 · doi:10.1016/j.hlc.2017.02.021
  88. Bravo, 2017, Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging, Int J Cardiol, 241, 457, 10.1016/j.ijcard.2017.03.033 · doi:10.1016/j.ijcard.2017.03.033
  89. Sperry, 2018, Prognostic impact of extent, severity, and heterogeneity of abnormalities on 18F-FDG PET scans for suspected cardiac sarcoidosis, JACC Cardiovasc Imaging, 11, 336, 10.1016/j.jcmg.2017.04.020 · doi:10.1016/j.jcmg.2017.04.020
  90. Hiraga, 2007, Diagnostic standard and guidelines for sarcoidosis, Jpn J Sarcoidosis Granulomatous Disord, 27, 89
  91. Agoston-Coldea, 2016, High mass (>18g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy-proven extracardiac sarcoidosis, Int J Cardiol, 222, 950, 10.1016/j.ijcard.2016.07.233 · doi:10.1016/j.ijcard.2016.07.233
  92. Flores, The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis, J Nucl Cardiol
  93. Alvi, 2019, Repeatability and optimization of FDG positron emission tomography for evaluation of cardiac sarcoidosis, JACC Cardiovasc Imaging, 12, 1284, 10.1016/j.jcmg.2019.01.011 · doi:10.1016/j.jcmg.2019.01.011
  94. Martineau, 2019, Imaging cardiac sarcoidosis with FLT-PET compared with FDG/perfusion-PET: a prospective pilot study, JACC Cardiovasc Imaging, 12, 2280, 10.1016/j.jcmg.2019.06.020 · doi:10.1016/j.jcmg.2019.06.020
  95. Hotta, 2018, 11C-4DST PET/CT imaging of cardiac sarcoidosis: comparison with 18-F-FDG and cardiac MRI, Clin Nucl Med, 43, 458, 10.1097/RLU.0000000000002059 · doi:10.1097/rlu.0000000000002059
  96. Alhamad, 2010, Sarcoidosis-associated pulmonary hypertension: clinical features and outcomes in Arab patients, Ann Thorac Med, 5, 86, 10.4103/1817-1737.62471 · doi:10.4103/1817-1737.62471
  97. Sulica, 2005, Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension, Chest, 128, 1483, 10.1378/chest.128.3.1483 · doi:10.1378/chest.128.3.1483
  98. Liu, 2017, Interventional therapy in sarcoidosis-associated pulmonary arterial stenosis and pulmonary hypertension, Clin Respir J, 11, 906, 10.1111/crj.12435 · doi:10.1111/crj.12435
  99. Maimon, 2013, Sarcoidosis-associated pulmonary hypertension in patients with near-normal lung function, Int J Tuberc Lung Dis, 17, 406, 10.5588/ijtld.12.0428 · doi:10.5588/ijtld.12.0428
  100. Pabst, 2013, Pulmonary arterial hypertension in patients with sarcoidosis: the Pulsar single center experience, Adv Exp Med Biol, 755, 299, 10.1007/978-94-007-4546-9_38 · doi:10.1007/978-94-007-4546-9_38
  101. Patel, 2016, Right heart involvement in patients with sarcoidosis, Echocardiography, 33, 734, 10.1111/echo.13163 · doi:10.1111/echo.13163
  102. Rapti, 2013, Elevated pulmonary arterial systolic pressure in patients with sarcoidosis: prevalence and risk factors, Hai, 191, 61
  103. Baughman, 2006, Pulmonary hypertension in sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, 23, 108
  104. Fisher, 2006, Sarcoidosis-associated pulmonary hypertension: outcome with long-term epoprostenol treatment, Chest, 130, 1481, 10.1378/chest.130.5.1481 · doi:10.1378/chest.130.5.1481
  105. Ford, 2016, Tadalafil therapy for sarcoidosis-associated pulmonary hypertension, Pulm Circ, 6, 557, 10.1086/688775 · doi:10.1086/688775

Cited by

See all 1,086

Metadata

Authors
Crouser, E. D., Maier, L. A., Wilson, K. C., Bonham, C. A., Morgenthau, A. S., Patterson, K. C., Abston, E., Bernstein, R. C., Blankstein, R., Chen, E. S., Culver, D. A., Drake, W., Drent, M., Gerke, A. K., Ghobrial, M., Govender, P., Hamzeh, N., James, W. E., Judson, M. A., Kellermeyer, L., Knight, S., Koth, L. L., Poletti, V., Raman, S. V., Tukey, M. H., Westney, G. E., & Baughman, R. P.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2020-04-15
Volume
201
Issue
8
Pages
e26-e51
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W3015330439
Cited by
1,086
References
98
FWCI
66.88
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.